AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN272201100031CXOMA LTD.
Overview
Award facts
- Net obligations
- $21.51M
- $21,508,794of $22.58M potential value
- Period of performance
- Sep 27, 2011 to Sep 29, 2016
- Ended
- Modifications
- 9
- Latest action Mar 30, 2020
- Contract type
- Definitive contract
- PIID HHSN272201100031C
Description of requirement
BROAD SPECTRUM MONOCLONAL ANTIBODY-BASED THERAPEUTIC FOR BOTULISM
Dates and value
- Award date
- Signed on Sep 27, 2011
- Potential end of performance
- Sep 28, 2016
- Current value
- $21,508,794Base and exercised options
- Potential value (if all options are exercised)
- $22,578,772
Obligations by fiscal year of action
- FY2016: -$5,497,592 (de-obligation)
- FY2015: $3,045,884
- FY2014: $10,911,937
- FY2013: $5,969,753
- FY2011: $7,078,812
Total across 5 fiscal years: $21,508,794
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 30, 2020. View on USAspending · Recipient on SAM.gov
Recipient
NameXOMA LTD.
LocationBERKELEY, CA
UEID4E6GZ22G2K5
CAGE code366Q7
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyXOMA LTD.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
- Place of performance
- Berkeley, Alameda County, California 94710-1364
- Congressional district (place of performance)
- CA-12As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 29
Solicitation and notices
- Solicitation ID
- NIHAI2010097(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Broad spectrum monoclonal antibody-based therapeutic for botulism
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 27, 2011Base obligation at award: $7,078,812
- Latest action
- Mar 30, 2020 — CloseoutModification P00009; administrative: no change in scope or value
- Latest substantive action
- Feb 25, 2015 — Option exercisedModification 5; obligation change +$3,045,884
- Actions by type
- Base award1
- Other administrative action4
- Option exercised3
- Closeout1
- Vendor address change1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 10
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930